Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: genetics – Page 392

Sharks Have a Secret Buried in Their DNA That Could Help Humans Fight Cancer

Sharks are at the top of the marine food chain for a reason. Their massive size along with a dazzling row of extra-sharp teeth make them the fiercest hunters in our oceans. But it turns out that the shark’s aquatic dominance reaches down into its very DNA, and through its mutations, sharks could teach us how to fight our most deadly affliction—cancer.

This isn’t the first evidence that mutations can prove beneficial for disease resistance and long-term survival. High bone density, a hemoglobin that boosts malaria resistance, and a third retinal cone that improves color vision are some human examples. But new gene mapping conducted by scientists at the Save Our Seas Foundation Shark Research Center at Florida’s Nova Southeastern University, the Guy Harvey Research Institute, and the Cornell University College of Veterinary Medicine shows that sharks have developed genomic adaptations that repair damaged DNA, effectively protecting them against cancer and other diseases.

Bio-Security — Dr. Tara O’Toole MD, EVP and Senior Fellow at In-Q-Tel, director of B.Next, former Under Secretary for the Science and Technology Directorate at the U.S. Department of Homeland Security (DHS) — ideaXme — Ira Pastor

https://www.youtube.com/watch?v=DXo5BVdzZQE&t=1s

Embrace human genome editing

Imagine then, the emancipatory potential of genome editing for these millions.

Realizing this potential, however, will require that genome editing meet with societal approval. The typical response right now when you talk to someone about genetic engineering or reproductive technology is a reference to ‘designer babies,’ eugenics, Nazism, and other evils. These arguments have a very powerful emotional hold over many people, but in my opinion, they simply don’t stand up to scrutiny.

Numerous traits, both physical and mental, are too complex to ever be able to engineer, and a Gattaca-like future of ‘designer babies’ is probably just as improbable as time-travel. No serious scientist or ethicist is advocating for government mandated ‘genetic correction’ of the sort Nazism or eugenics implies. As for physical appearance, everyone has their own ideas about the ‘physical ideal.’ Not every visitor to a cosmetic surgeon comes out looking Northern European.

Scientists explore how females shut off their second X chromosome

Researchers at the European Molecular Biology Laboratory (EMBL) in Heidelberg and Institut Curie in Paris have shown that the protein SPEN plays a crucial role in the process of X-chromosome inactivation, whereby female mammalian embryos silence gene expression on one of their two X chromosomes.

In their landmark research published in Nature on 5 February, the scientists reveal how SPEN targets and silences active on the X chromosome, providing important new insights into the molecular basis of X-inactivation.

In mammals, males and females differ genetically in their sex chromosomes—XX in females and XY in males. This leads to a potential imbalance, as more than a thousand genes on the X chromosome would be expressed in a double dose in females compared to males. To avoid this imbalance, which has been shown to lead to early embryonic lethality, female embryos shut down the expression of genes on one of their two X .

U.S. Trial Finds CRISPR-Edited Cells Are Safe in Cancer Patients

For years, scientists have hoped to use the gene-editing technology CRISPR to help treat all sorts of diseases, including cancer. Now for the first time in the U.S., researchers say they’ve shown that CRISPR-edited immune cells can be safely given to cancer patients and survive for up to nine months—a finding that may signal CRISPR’s future as part of an emerging cancer treatment known as immunotherapy.

The idea that we can boost the human immune system to help it fight off cancer isn’t new. But it’s only recently that researchers have been able to make substantial advances in the field. There are different techniques, but one that’s received lots of attention involves reprogramming our immune system’s shock troops, known as T cells, to attack cancer. T cells are drawn out from a patient’s blood, grown and modified in the lab so that they target tumor cells, and then reintroduced back into the body.

Cancer’s genetic secrets revealed through massive international study

Cancer is a hugely complicated disease, and understanding how it starts and how it can be treated requires an equally enormous effort from scientists. That effort is well underway with the Pan-Cancer Project, an international collaboration dedicated to analyzing thousands of whole cancer genomes. And now, the comprehensive results are being published in 23 separate papers, revealing new details about cancer’s causes and development, and how it can be classified, diagnosed and treated.

Otherwise known as the Pan-Cancer Analysis of Whole Genomes (PCAWG) Project, the collaboration involves over 1,300 scientists from 37 countries. These researchers analyzed over 2,600 whole cancer genomes of 38 different types of tumors, probing deeper than ever into how the disease alters DNA.

One of the most optimistic outlooks from the project is that while the cancer genome is incredibly complex, it’s also finite. That means that it should be technically possible to document every genetic change that cancer can possibly induce. That information can then be used to diagnose which type of tumor a patient has and personalize a treatment plan based on the unique genome of their cancer.